Novo Nordisk A/S reported DKK1.4T in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Bausch Health Companies USD 2.61B 200M Jun/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Eli Lilly USD 1.13T 260.54B Jun/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Novartis USD 240.59B 67.17B Jun/2026
Novo Nordisk DKK 212.17B 55.02B Jun/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Pacira USD 998M 83M Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Supernus Pharmaceuticals USD 2.7B 277M Jun/2026